--- title: "Pre-Market Movers: TNGX, WOK, GOCO Set The Path" type: "News" locale: "en" url: "https://longbridge.com/en/news/289061684.md" description: "Biotech stocks showed significant pre-market volatility on Monday, driven by clinical data and financing news. Tango Therapeutics (TNGX) led gainers with a 45% rise to $29.27, followed by WORK Medical Technology (WOK) up 19%. Conversely, GoHealth (GOCO) was the top loser, dropping 38% to $0.42, while Clearmind Medicine (CMND) fell 21%. Other notable movers included Nurix Therapeutics and Aditxt." datetime: "2026-06-08T13:15:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289061684.md) - [en](https://longbridge.com/en/news/289061684.md) - [zh-HK](https://longbridge.com/zh-HK/news/289061684.md) --- # Pre-Market Movers: TNGX, WOK, GOCO Set The Path (RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. Price swings ahead of the opening bell are being driven by positive clinical trial data, agreements, financing deals, and corporate restructuring announcements. **In the Green - Premarket Gainers** On Monday, the following stocks were trading significantly higher in the pre-market session. 1\. Tango Therapeutics, Inc. (TNGX) - up 45% at $29.27 2. WORK Medical Technology Group LTD. (WOK) - up 19% at $0.10 3. Nurix Therapeutics, Inc. (NRIX) - up 13% at $16.50 4. Eledon Pharmaceuticals, Inc. (ELDN) - up 10% at $3.74 5. Cardio Diagnostics Holdings, Inc. (CDIO) - up 9% at $2.13 6. Aldeyra Therapeutics, Inc. (ALDX) - up 9% at $1.77 7. RenovoRx, Inc. (RNXT) - up 9% at $0.94 8. Cullinan Therapeutics, Inc. (CGEM) - up 8% at $14.65 9. Werewolf Therapeutics, Inc. (HOWL) - up 7% at $0.42 10. China Pharma Holdings, Inc. (CPHI) - up 5% at $0.75 **In the Red - Premarket Losers** The following stocks were trading lower in the premarket session on Monday. 1\. GoHealth, Inc. (GOCO) - down 38% at $0.42 2. Clearmind Medicine Inc. (CMND) - down 21% at $3.15 3. Aditxt, Inc. (ADTX) - down 19% at $0.05 4. Nuwellis, Inc. (NUWE) - down 17% at $0.13 5. SciSparc Ltd. (SPRC) - down 15% at $9.68 6. Vivos Therapeutics, Inc. (VVOS) - down 10% at $0.78 7. Apimeds Pharmaceuticals US, Inc. (APUS) -down 9% at $1.15 8. InMed Pharmaceuticals Inc. (INM) - down 7% at $1.47 9. Virax Biolabs Group Limited. (VRAX) - down 7% at $0.19 10. BioCardia, Inc. (BCDA) - down 4% at $0.98 For More Such Biotech Stock News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. ### Related Stocks - [TNGX.US](https://longbridge.com/en/quote/TNGX.US.md) - [GOCO.US](https://longbridge.com/en/quote/GOCO.US.md) - [NRIX.US](https://longbridge.com/en/quote/NRIX.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [CMND.US](https://longbridge.com/en/quote/CMND.US.md) - [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md) - [CDIO.US](https://longbridge.com/en/quote/CDIO.US.md) - [ALDX.US](https://longbridge.com/en/quote/ALDX.US.md) - [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md) - [CGEM.US](https://longbridge.com/en/quote/CGEM.US.md) - [HOWL.US](https://longbridge.com/en/quote/HOWL.US.md) - [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md) - [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md) - [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md) - [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md) - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [INM.US](https://longbridge.com/en/quote/INM.US.md) - [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md) - [BCDA.US](https://longbridge.com/en/quote/BCDA.US.md) - [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md) - [CDIOW.US](https://longbridge.com/en/quote/CDIOW.US.md) ## Related News & Research - [Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million | ADTX Stock News](https://longbridge.com/en/news/289184727.md) - [](https://longbridge.com/en/news/289066296.md) - [Why Tango Therapeutics (TNGX) Is Up 33.9% After Highlighting Pancreatic Cancer Pipeline Data Prospects](https://longbridge.com/en/news/289140698.md) - [Tango soars on early-stage data for vopimetostat in pancreatic cancer](https://longbridge.com/en/news/289075655.md) - [Tango Therapeutics' pancreatic cancer drug combo shows promise in study](https://longbridge.com/en/news/289053428.md)